Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aptevo Therapeutics Inc (APVO)

Aptevo Therapeutics Inc (APVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,530
  • Shares Outstanding, K 45,099
  • Annual Sales, $ 23,070 K
  • Annual Income, $ -53,690 K
  • 60-Month Beta 2.39
  • Price/Sales 1.50
  • Price/Cash Flow N/A
  • Price/Book 1.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/08/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.36
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.46
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.49 +59.18%
on 08/12/19
1.02 -23.53%
on 08/01/19
-0.09 (-10.09%)
since 07/19/19
3-Month
0.49 +59.18%
on 08/12/19
1.04 -25.00%
on 06/20/19
+0.01 (+1.80%)
since 05/20/19
52-Week
0.49 +59.18%
on 08/12/19
5.73 -86.39%
on 09/04/18
-4.52 (-85.28%)
since 08/20/18

Most Recent Stories

More News
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results

Reports Positive Preliminary Top-Line Safety Data for APVO210

APVO : 0.78 (-3.70%)
Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today the receipt of a $4.3 million milestone payment from Saol...

APVO : 0.78 (-3.70%)
Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials

Completes Dosing in Single Ascending Dose (SAD) Phase 1 Study of APVO210

APVO : 0.78 (-3.70%)
Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients

Expands Options for Patients with Potential for

APVO : 0.78 (-3.70%)
Aptevo Therapeutics Reports First Quarter 2019 Financial Results

Achieves 73% Increase in First Quarter 2019 Year-Over-Year IXINITY(R) Net Revenue

APVO : 0.78 (-3.70%)
5 Stocks to Gain From Dollar's Recent Strength

The U.S. dollar hits an almost 2-year record high as global central banks turn dovish and German business moral deteriorates.

GTIM : 1.90 (+0.38%)
BFIN : 11.50 (-1.12%)
APVO : 0.78 (-3.70%)
HIIQ : 18.75 (+9.46%)
ADES : 12.02 (+0.84%)
Research Report Identifies Fastenal, Ideal Power, Fuel Tech, CTI BioPharma, Aptevo Therapeutics, and Caseys General Stores with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fastenal Company (NASDAQ:FAST),...

IPWR : 3.14 (+12.14%)
CTIC : 0.68 (+2.27%)
FTEK : 0.87 (-1.19%)
APVO : 0.78 (-3.70%)
CASY : 171.58 (-0.23%)
FAST : 30.48 (-0.59%)
Aptevo Therapeutics Reports IXINITY(R) and Pipeline Progress

Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019

APVO : 0.78 (-3.70%)
Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting

APVO436 Preclinical Data Continue to Show Promising Results Supporting Clinical Development for the Treatment of Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) and Differentiation...

APVO : 0.78 (-3.70%)
Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced that preclinical data for two of its ADAPTIR(TM)...

APVO : 0.78 (-3.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade APVO with:

Business Summary

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics...

See More

Key Turning Points

2nd Resistance Point 0.83
1st Resistance Point 0.81
Last Price 0.78
1st Support Level 0.77
2nd Support Level 0.75

See More

52-Week High 5.73
Fibonacci 61.8% 3.73
Fibonacci 50% 3.11
Fibonacci 38.2% 2.49
Last Price 0.78
52-Week Low 0.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar